title: [The results of using cytoflavin in conservative treatment of patients with obliterating atherosclerosis of the lower extremity vessels].
abstract: Results of conservative treatment of 31 patients with PAD are presented. In 3 and 6 months after 10 everyday intravenous infusions of Cytoflavin (combination of succinic acid, inosine, nicitinamide and riboflavin) average increase of painfree walking distance among nonsmokers was 50.6% and 64.4% vs. 108.0% and 170.5% in subgroup of smokers respectively. Average increase of maximal walking distance in subgroup of nonsmoking and smoking patients was respectively 30.1% and 130.5% in three months and 37.6% and 144.8% in 6 months after Cytoflavin infusions.
authors.forename: M S
authors.initials: MS
authors.lastname: Bogomolov
authors.forename: V M
authors.initials: VM
authors.lastname: Sedov
authors.forename: L N
authors.initials: LN
authors.lastname: Edovina
authors.forename: Iu V
authors.initials: IuV
authors.lastname: Luk'ianov
authors.forename: V V
authors.initials: VV
authors.lastname: Slobodianiuk
mesh_terms: D000368:Aged; D001162:Arteriosclerosis Obliterans / Q000188:drug therapy* / Q000503:physiopathology; D004305:Dose-Response Relationship, Drug; D004338:Drug Combinations; D005260:Female; D005486:Flavin Mononucleotide / Q000008:administration & dosage / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006801:Humans; D007262:Infusions, Intravenous; D007290:Inosine Diphosphate / Q000008:administration & dosage / Q000627:therapeutic use*; D007866:Leg / Q000098:blood supply*; D008297:Male; D008875:Middle Aged; D009536:Niacinamide / Q000008:administration & dosage / Q000627:therapeutic use*; D013386:Succinates / Q000008:administration & dosage / Q000627:therapeutic use*; D016896:Treatment Outcome; D016138:Walking / Q000502:physiology
chemical_list: D004338:Drug Combinations; D013386:Succinates; C507879:cytoflavin; D009536:Niacinamide; D005486:Flavin Mononucleotide; D007290:Inosine Diphosphate